In an earlier blog post about Christopher Nolan's latest blockbuster movie, Interstellar, I lauded the film for its ambition, ...

When California outlawed transcript withholding in 2020, the state positioned itself at the forefront of a quiet but ...

Market research is shifting to real-time, AI-native workflows. Here are seven trends that will redefine insights in 2026 and ...

Q1 2026 Earnings Call Transcript December 18, 2025 FactSet Research Systems Inc. beats earnings expectations. Reported EPS is $4.51, expectations were $4.36. Operator: Good day. Thank you for standing ...

Michela Tindera talks to Elliot Smither, Ethan Salathiel of KPMG, Carolina Garces of Citi and Helen Child of Open Banking ...

Former CBS News investigative correspondent Catherine Herridge discusses her tenure at the network, the internal response to ...

Lam Research Corporation (NASDAQ:LRCX) Q2 2025 Earnings Call Transcript January 29, 2025 Lam Research Corporation beats earnings expectations. Reported EPS is $0.91, expectations were $0.878. Operator ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Good afternoon. Thank you all for your interest in joining us. We're so pleased to host Alistair Baker, the Senior Vice President, Investor Relations and Corporate Development of Royal Gold. Royal ...

Cuts to scientific research focused disproportionately on research around diversity equity and inclusion. Some researchers say we're just beginning to understand the impact.

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.